Matches in Wikidata for { <http://www.wikidata.org/entity/Q63394013> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q63394013 description "clinical trial" @default.
- Q63394013 description "ensayu clínicu" @default.
- Q63394013 description "klinisch onderzoek" @default.
- Q63394013 description "клінічне випробування" @default.
- Q63394013 name "Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)" @default.
- Q63394013 type Item @default.
- Q63394013 label "Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)" @default.
- Q63394013 prefLabel "Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)" @default.
- Q63394013 P1050 Q63394013-56CF2584-4ADD-4EB3-B07A-85FF20D91580 @default.
- Q63394013 P1050 Q63394013-B680A9E9-51F3-49F7-8B0A-CB299A2C6CEF @default.
- Q63394013 P1132 Q63394013-EC14A82A-F8A3-45C8-B442-86F6C2C581A5 @default.
- Q63394013 P1476 Q63394013-EE7F5972-964E-4A43-8780-B8458AE4DACF @default.
- Q63394013 P17 Q63394013-8C61796A-BB55-47E1-85BD-0F396CCB6D45 @default.
- Q63394013 P17 Q63394013-CBC646F5-A9D5-4B33-B2A4-50D58A0DEA72 @default.
- Q63394013 P17 Q63394013-CCE38796-4637-4A8E-A4E4-1CEA851F92E8 @default.
- Q63394013 P1813 Q63394013-DCB951A3-3EB3-4B95-8C8D-03CB6B294F61 @default.
- Q63394013 P2899 Q63394013-E06F1603-0AF8-4216-98B8-55A4111FC2D0 @default.
- Q63394013 P3098 Q63394013-D97B51E3-D991-497C-9164-5B0FD49506E5 @default.
- Q63394013 P31 Q63394013-09C3DA30-A132-42E4-9A23-292F63EDB508 @default.
- Q63394013 P4135 Q63394013-A80097F9-A8CA-4480-BCB0-9F717A7C5485 @default.
- Q63394013 P580 Q63394013-6063997F-FDFF-4342-BC74-E6412B6290CC @default.
- Q63394013 P582 Q63394013-64D1E962-E468-440C-8DDA-AF4D35809F9E @default.
- Q63394013 P6099 Q63394013-506944AB-3B51-4911-9189-F6B9A1117DA6 @default.
- Q63394013 P6099 Q63394013-ED65DF45-2C1B-4167-87E0-8E93919248AA @default.
- Q63394013 P6153 Q63394013-35DCA7C0-6BBB-44C0-818B-1665C37572DC @default.
- Q63394013 P6153 Q63394013-543E0593-4FD1-430E-BC8D-77F8B1584196 @default.
- Q63394013 P6153 Q63394013-68895A2E-3D9B-4790-BCB2-874CC83206F2 @default.
- Q63394013 P6153 Q63394013-AB65926F-01A6-484E-B715-F60B2EB0223D @default.
- Q63394013 P6153 Q63394013-B11B0007-C45A-4474-A15F-30F1EA309AD6 @default.
- Q63394013 P8363 Q63394013-70750F61-625E-4BA6-BC46-3E25FFB5D362 @default.
- Q63394013 P1050 Q179630 @default.
- Q63394013 P1050 Q221472 @default.
- Q63394013 P1132 "+204" @default.
- Q63394013 P1476 "A Randomized, Double-Blind, Placebo-Controlled Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With Fragile X Syndrome" @default.
- Q63394013 P17 Q30 @default.
- Q63394013 P17 Q408 @default.
- Q63394013 P17 Q664 @default.
- Q63394013 P1813 "CONNECT-FX" @default.
- Q63394013 P2899 "+3" @default.
- Q63394013 P3098 "NCT03614663" @default.
- Q63394013 P31 Q30612 @default.
- Q63394013 P4135 "+17" @default.
- Q63394013 P580 "2018-06-12T00:00:00Z" @default.
- Q63394013 P582 "2019-07-23T00:00:00Z" @default.
- Q63394013 P6099 Q42824440 @default.
- Q63394013 P6099 Q42824827 @default.
- Q63394013 P6153 Q1047060 @default.
- Q63394013 P6153 Q1535116 @default.
- Q63394013 P6153 Q18156816 @default.
- Q63394013 P6153 Q30281662 @default.
- Q63394013 P6153 Q5120231 @default.
- Q63394013 P8363 Q78089383 @default.